Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
search
Subscribe
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
Subscribe
FREE
Edition
European
US
Urology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
PARP Inhibitors Transform Prostate Cancer Treatment
October 2025
Financial challenges, comorbidities, and drug interactions may limit access, while systemic inequities contribute to racial and ethnic disparities.
Read more
26 Jun 2017
Significant Improvement in Prostate Cancer Survival Rates Found
SIGNIFICANT improvements to survival rates in prostate cancer patients have been found to result from the addition of abiraterone to hormone therapy at…
8 Jun 2017
Abiraterone Acetate Plus Prednisone Provided Significant Clinical Benefit in Patients with High-Risk Metastatic Hormone-Naïve Prostate Cancer (mHNPC), Improving Overall Survival and Radiographic Progression-Free Survival
Beerse, Belgium, 3 June, 2017 – Janssen-Cilag International NV today announced data from the pivotal Phase 3 LATITUDE clinical trial, which showed Zytiga…
3 May 2017
Mental Health Education Should Be as Important as Going to School, Expert Warns
According to recent headlines, mental health education should also be taught in schools. The recent debate has been sparked by a petition spearheaded by…
5 Apr 2017
Australia’s Bionic Vision Technologies Raises US$18 Million (AU$23.5 M) to Develop ‘Bionic Eye’ for Global Markets
Melbourne, Australia, April 03, 2017 – Retinal implant innovator Bionic Vision Technologies (BVT) today announced it had raised US $18 million…
27 Mar 2017
Pembrolizumab Improves Survival as a Second-Line Treatment for Urothelial Cancer
PEMBROLIZUMAB, a highly selective, humanised monoclonal antibody targeting programmed cell death 1 (PD-1), has a superior safety profile and improved…
13 Jan 2017
Urine Test Can Tell You How Healthy Your Diet Is
RESEARCHERS have developed a test that uses urine samples that indicate what food a person has been eating, allowing them to monitor how healthy their…
10 Jan 2017
Introducing EMJ Innovations 1.1
United Kingdom, January 10, 2017: Happy new year and welcome to our first journal of the year, the inaugural edition of the European Medical Journal…
9 Jan 2017
Low Levels of Physical Activity Can Still Improve Happiness
THE RESULTS of a large study that used the smartphones of over 10,000 participants show that small amounts of physical activity, or non-exercise activity…
Loading posts...
« Previous
1
…
33
34
35
36
37
…
39
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View